Urogen Pharma

URGN13F as of Jun 30, 2026 · next update ~Nov 14

Limited coverage

Only 1 fund we track owns this stock, so quarterly sentiment and aggregates may be sparse.

Who's buying URGN

Top funds mostly added to Urogen Pharma in Q2 (Apr⁠–⁠Jun)

Buying:

Funds1InsidersCongress

Top funds
1 of 1 bought more, 0 sold some. Largest: Polen Capital Management, $1.1M (0% of its portfolio).
Insiders
No buys, 11 sales in 12 months.
Congress
No trades disclosed in the last 12 months.

1 fund$1.1M held0.0% avg. weightQ2: 1 bought / 0 sold

13F reports are a snapshot as of Jun 30, 2026; funds may have traded since. Insiders often sell for personal reasons (taxes, diversification, planned sales).

Share price · market data, not from 13F reports

Q2 2026

Insider trades (Form 4)

Last 2 years · 20 filings

Date	Insider	Type	Shares	Price	Value
Oct 8, 2026	Chris Degnan CFO	Sold	2,202	$36.69	$81K
Sep 8, 2026	Mark Schoenberg	Sold	871	$42.92	$37K
Sep 8, 2026	Jason Drew Smith	Sold	1,519	$42.54	$65K
Aug 20, 2026	Mark Schoenberg	Sold	60,677	$47.05	$2.85M
Jul 9, 2026	Mark Schoenberg	Sold	10,000	$40.00	$400K
Jun 22, 2026	Mark Schoenberg	Sold	10,000	$35.01	$350K
Jun 8, 2026	Mark Schoenberg	Sold	5,222	$27.30	$143K
May 8, 2026	Mark Schoenberg	Sold	10,000	$30.00	$300K
Feb 3, 2026	Jason Drew Smith	Sold	7,479	$19.69	$147K
Feb 3, 2026	Mark Schoenberg	Sold	7,373	$19.69	$145K
Nov 19, 2025	Mark Schoenberg	Sold	10,000	$25.00	$250K
Oct 8, 2025	Chris Degnan CFO	Sold	2,203	$16.85	$37K
Sep 8, 2025	Mark Schoenberg	Sold	871	$19.11	$17K
Sep 8, 2025	Jason Drew Smith	Sold	1,520	$19.11	$29K
Aug 11, 2025	Mark Schoenberg	Sold	10,000	$17.69	$177K
Jul 28, 2025	Jason Drew Smith	Sold	7,522	$19.14	$144K
Jul 28, 2025	Mark Schoenberg	Sold	5,149	$19.14	$99K
Jun 9, 2025	Mark Schoenberg	Sold	5,162	$7.37	$38K
Jan 31, 2025	Mark Schoenberg	Sold	4,551	$11.14	$51K
Jan 31, 2025	Jason Drew Smith	Sold	7,379	$11.14	$82K